By Newsbreak Producer Matthew Veeran - In a world first, England's NHS is rolling out a "Trojan horse" therapy for multiple myeloma, offering patients nearly three times longer remission than current treatments. This innovative antibody-drug, precisely targets and delivers a potent chemotherapy drug directly into cancer cells, significantly reducing side effects and providing "life-changing" outcomes for patients. While not a cure, this advanced treatment - which has shown to halt the blood cancer for three years compared to 13 months with previous therapies - marks a significant step towards long-term remission. I found out more about it in this week's Medical Monitor... 

<p>By Newsbreak Producer Matthew Veeran - In a world first, England's NHS is rolling out a "Trojan horse" therapy for multiple myeloma, offering patients nearly three times longer remission than current treatments. This innovative antibody-drug, precisely targets and delivers a potent chemotherapy drug directly into cancer cells, significantly reducing side effects and providing "life-changing" outcomes for patients. While not a cure, this advanced treatment - which has shown to halt the blood cancer for three years compared to 13 months with previous therapies - marks a significant step towards long-term remission. I found out more about it in this week's Medical Monitor...&nbsp;</p>

Award-winning Current Affairs programme and News talk show. Brought to you by SABC News.

<p>Award-winning Current Affairs programme and News talk show. Brought to you by SABC News.</p>